evidence table

Citrus Bergamot Lipid Profile Randomized Trial Evidence Table

Structured evidence table for Citrus Bergamot Lipid Profile Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Citrus Bergamot Lipid Profile Randomized Trial1 2 3 Obesity is a multifactorial disease defined as abnormal or excessive fat accumulation that presents a risk to health because it is a major risk factor for several noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and several types of cancer [].1Pujia Carmelo (2026)Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Citrus Bergamot Lipid Profile Randomized TrialFurthermore, obesity and its associated health problems have a significant economic impact on the global healthcare system [,].1Pujia Carmelo (2026)Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Citrus Bergamot Lipid Profile Randomized TrialIt is well known that a weight loss of between 5% and 10% is sufficient to achieve clinically significant improvements in health risk factors [].1Pujia Carmelo (2026)Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Citrus Bergamot Lipid Profile Randomized TrialIt is a major public health concern that has reached pandemic proportions worldwide.1Pujia Carmelo (2026)Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Citrus Bergamot Lipid Profile Randomized TrialMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has emerged as the most prevalent chronic liver disease worldwide, with an overall global prevalence of 30% [...].4Rodriguez-Ramiro I (2026)Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside.
topicCitrus Bergamot Lipid Profile Randomized Trial
claim1 2 3 Obesity is a multifactorial disease defined as abnormal or excessive fat accumulation that presents a risk to health because it is a major risk factor for several noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and several types of cancer [].
evidence level1
citationPujia Carmelo (2026)
sourceEffect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
topicCitrus Bergamot Lipid Profile Randomized Trial
claimFurthermore, obesity and its associated health problems have a significant economic impact on the global healthcare system [,].
evidence level1
citationPujia Carmelo (2026)
sourceEffect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
topicCitrus Bergamot Lipid Profile Randomized Trial
claimIt is well known that a weight loss of between 5% and 10% is sufficient to achieve clinically significant improvements in health risk factors [].
evidence level1
citationPujia Carmelo (2026)
sourceEffect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
topicCitrus Bergamot Lipid Profile Randomized Trial
claimIt is a major public health concern that has reached pandemic proportions worldwide.
evidence level1
citationPujia Carmelo (2026)
sourceEffect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
topicCitrus Bergamot Lipid Profile Randomized Trial
claimMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has emerged as the most prevalent chronic liver disease worldwide, with an overall global prevalence of 30% [...].
evidence level4
citationRodriguez-Ramiro I (2026)
sourceAdvances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside.

Learn next

Related evidence and supplement guides

GuideCitrus Bergamot Lipid Profile Randomized Trial: What the Evidence SaysCitrus Bergamot Lipid Profile Randomized Trial has 2 source documents in the current Migaku evid...GuideCitrus Bergamot Lipid Profile Meta-analysis: What the Evidence SaysCitrus Bergamot Lipid Profile Meta-analysis has 2 source documents in the current Migaku evidenc...GuideCitrus Bergamot Blood Lipids Meta-analysis: What the Evidence SaysCitrus Bergamot Blood Lipids Meta-analysis has 2 source documents in the current Migaku evidence...GuideCashew Lipid Profile Randomized Trial: What the Evidence SaysCashew Lipid Profile Randomized Trial has 1 source documents in the current Migaku evidence data...AnswerDoes Citrus Bergamot Blood Lipids Meta-Analysis work?Citrus Bergamot Blood Lipids Meta-Analysis has evidence relevant to strength of evidence and wha...AnswerIs Citrus Bergamot Blood Lipids Meta-Analysis safe?Citrus Bergamot Blood Lipids Meta-Analysis has evidence relevant to safety, limits, and clinicia...AnswerWhat does the evidence say about Citrus Bergamot Blood Lipids Meta-Analysis?Citrus Bergamot Blood Lipids Meta-Analysis has evidence relevant to benefits, uncertainty, and p...AnswerDoes Cashew Lipid Profile Randomized Trial work?Cashew Lipid Profile Randomized Trial has evidence relevant to strength of evidence and what the...

Source documents

  1. Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
  2. Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside.